Aptamer Group PLC is a UK-based company specializing in custom antibody alternatives and related research and development services. Established in 2014, Aptamer Group operates as a privately held company with a focus on biotechnology, particularly within the rapidly evolving field of antibody discovery and optimization. The company’s core business centers on the design, synthesis, and production of specialized antibodies tailored to specific research needs. Aptamer Group offers a comprehensive suite of services encompassing antibody development, modification, and validation, catering to a diverse clientele including pharmaceutical companies, diagnostic laboratories, and bioprocessing facilities. Aptamer Group’s expertise spans a range of applications, including antibody alternatives for diagnostic assays, biopharmaceutical development, and therapeutic research. They leverage advanced techniques and a dedicated team of scientists to provide bespoke solutions, emphasizing high affinity and selectivity in their antibody products. The company’s international presence allows for collaboration and service delivery globally. As a Skilled Worker, Aptamer Group is eligible for visa sponsorship, reflecting its commitment to skilled workforce employment. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology. Furthermore, they operate within the following industries: Biotechnology, Diagnostics, Pharmaceutical Research, and Bioprocessing.

Aptamer Group PLC is a UK-based company specializing in custom antibody alternatives and related research and development services. Established in 2014, Aptamer Group operates as a privately held company with a focus on biotechnology, particularly within the rapidly evolving field of antibody discovery and optimization. The company’s core business centers on the design, synthesis, and production of specialized antibodies tailored to specific research needs. Aptamer Group offers a comprehensive suite of services encompassing antibody development, modification, and validation, catering to a diverse clientele including pharmaceutical companies, diagnostic laboratories, and bioprocessing facilities. Aptamer Group’s expertise spans a range of applications, including antibody alternatives for diagnostic assays, biopharmaceutical development, and therapeutic research. They leverage advanced techniques and a dedicated team of scientists to provide bespoke solutions, emphasizing high affinity and selectivity in their antibody products. The company’s international presence allows for collaboration and service delivery globally. As a Skilled Worker, Aptamer Group is eligible for visa sponsorship, reflecting its commitment to skilled workforce employment. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology. Furthermore, they operate within the following industries: Biotechnology, Diagnostics, Pharmaceutical Research, and Bioprocessing.